Source: Fox News
Summary
Researchers at the Weizmann Institute of Science in Israel have found that Viagra’s active ingredient, sildenafil, may have properties that can prevent cancer from spreading. The study, published by the American Association for Cancer Research, analyzed human and mouse cancer cells, genetic experiments, and 20 years of health data from 5 million patients. The team found that sildenafil limits the cancer cell’s ability to use cholesterol, which is essential for the cell to break away from the primary tumor and migrate throughout the body.
Our Reading
The advice sounds familiar.
Viagra, originally developed to treat high blood pressure and chest pain, was later found to have an unexpected effect on erectile function during clinical trials. Now, researchers suggest it may have benefits for cancer patients. The study’s findings highlight the importance of treating the whole patient, not just the cancer, when tailoring the most effective therapy.
Cancer biology is shaped not only by mutations in tumor cells but also by the patient’s metabolic state and medications they are already taking for other conditions. The study’s use of mouse models and observational human evidence may pose limitations to the final implications.
It’s another example of how health guidance can shift and rebrand itself.
